Reshape Bio Raises $8 Million to Automate Experimental Tasks and Build New Infrastructure for Food, Agriculture and Microbial Research

Investment marks Denmark’s largest seed round, funding an integrated hardware and software platform to accelerate discovery, reduce errors and eliminate cumbersome manual experimentation COPENHAGEN, Denmark -- Reshape Biotech, an integrated hardware and software platform digitizing microbiology experiments, today announced an $8.1 million investment, Denmark’s largest-ever seed round. The oversubscribed investment was led by ACME Capital, with [...]

Rigaku to Supply Two XtaLAB Synergy-ED Electron Diffractometers to UK’s Leading Crystallography Facility

The National Crystallography Service (NCS) is a critical component of the UK’s research infrastructure, providing access to world-leading research facilities across the nation, underpinning many scientific discoveries and developments. To ensure the NCS continues to provide cutting-edge capabilities, they will establish the National Electron Diffraction Facility, which will feature Rigaku XtaLAB Synergy-ED electron diffractometers, opening [...]

Eurofins Genomics US Launches Express Oxford Nanopore Sequencing Service with Same-Day Results

LOUISVILLE, Ky. -- Eurofins Genomics US, the global leader in sequencing, launches a revolutionary new, low cost, whole plasmid sequencing service with same-day results. The company expanded its already massive sequencing infrastructure in Louisville to include Nanopore sequencing capabilities. Eurofins Genomics US Launches Express Oxford Nanopore Sequencing Service with Same-Day Results Located next to the [...]

AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva’s latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies

AcuraBio selects Cytiva’s latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapies The latest purification technology will offer efficient processing time for plasmid DNA production Brisbane, Australia – AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), [...]

SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times

Montpellier:  SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving the diagnosis and management of patients suspected of suffering from thrombotic microangiopathies and atypical Hemolytic syndrome (aHUS).  The program involved using Oxford Nanopore’s revolutionary technology to sequence patients at the bedside, dramatically reducing turnaround times [...]

New Autograph AGX-V2 Series Precision Universal Testing Machines Incorporate World’s First Voice Operation Device to Provide Accurate and Safe Testing

Autograph AGX-V2 Series Precision Universal Testing Machines (Left: Large Color LCD Touch Panel Equipped Model, table-top model; Right: Standard Model, floor model) Shimadzu Corporation announces the release of the Autograph AGX-V2 series precision universal testing machines. This is the world’s first series of testing machines equipped with a voice operation device. The series consists of [...]

KNAUER IS PART OF THE JOINT-RESEARCH CONSORTIUM NANOFACT TO ADVANCE NANOMEDICINE MANUFACTURING

The institutions Gattefossé, InProcess-LSP, Knauer, Microfluidics, Skyepharma, and the University of Graz join the RCPE-led European Consortium for Continuous Pharmaceutical Manufacturing (ECCPM) to jointly develop a modular, flexible toolkit to advance industrial-scale production of lipid nanoparticles. The ECCPM, founded and led by the Research Center Pharmaceutical Engineering (RCPE), announces the establishment of NanoFacT, a joint-research [...]

Japanese collaboration agreement extended to allow final evaluation of performance on clinical samples

In December 2019, AcouSort announced that the company had signed an agreement with a major Japanese industrial player regarding the lease of one AcouWash system and accompanying application support. The system has been used for sample preparation in an R&D project aiming to develop and evaluate the potential of a new diagnostic assay. The evaluation [...]

Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto

WASHINGTON -- Danaher Corporation (NYSE: DHR) ("Danaher") today announced that Veralto Corporation ("Veralto" or the "Company") will be the name of the separate public company Danaher intends to create in the fourth quarter of 2023. Veralto will be comprised of an outstanding collection of market-leading brands in Danaher's Environmental and Applied Solutions (EAS) segment:  Hach, ChemTreat, [...]

Bio-Rad and Element Biosciences Partner to Deliver Seamless RNA Sequencing Workflow Between Element’s AVITI™ System and Bio-Rad’s SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits

HERCULES, Calif., and SAN DIEGO, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and Element Biosciences, Inc., developer of a new DNA sequencing platform disrupting genomics, today announced a partnership to demonstrate the capabilities of the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio [...]

Access IBO on Knowledge Center